日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Integrative pathway analysis across humans and 3D cellular models identifies the p38 MAPK-MK2 axis as a therapeutic target for Alzheimer's disease.

对人类和 3D 细胞模型进行整合通路分析，确定 p38 MAPK-MK2 轴是阿尔茨海默病的一种治疗靶点

期刊:Neuron
影响因子:15
doi:10.1016/j.neuron.2024.10.029
Naderi Yeganeh Pourya, Kwak Sang Su, Jorfi Mehdi, Koler Katjuša, Kalatturu Thejesh, von Maydell Djuna, Liu Zhiqing, Guo Kevin, Choi Younjung, Park Joseph, Abarca Nelson, Bakiasi Grisilda, Cetinbas Murat, Sadreyev Ruslan, Griciuc Ana, Quinti Luisa, Choi Se Hoon, Xia Weiming, Tanzi Rudolph E, Hide Winston, Kim Doo Yeon
细胞生物学
p38 MAPK
Human
发表日期：2025
文献求助 收藏

Evaluation of bumetanide as a potential therapeutic agent for Alzheimer's disease

评估布美他尼作为阿尔茨海默病潜在治疗药物的疗效

期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2023.1190402
Boyarko, Ben; Podvin, Sonia; Greenberg, Barry; Momper, Jeremiah D; Huang, Yadong; Gerwick, William H; Bang, Anne G; Quinti, Luisa; Griciuc, Ana; Kim, Doo Yeon; Tanzi, Rudolph E; Feldman, Howard H; Hook, Vivian
阿尔茨海默症
发表日期：2023
文献求助 收藏

Pharmacological and Toxicological Properties of the Potent Oral γ-Secretase Modulator BPN-15606

强效口服γ-分泌酶调节剂BPN-15606的药理学和毒理学特性

期刊:Journal of Pharmacology and Experimental Therapeutics
影响因子:3.8
doi:10.1124/jpet.117.240861
Wagner, Steven L; Rynearson, Kevin D; Duddy, Steven K; Zhang, Can; Nguyen, Phuong D; Becker, Ann; Vo, Uyen; Masliah, Deborah; Monte, Louise; Klee, Justin B; Echmalian, Corinne M; Xia, Weiming; Quinti, Luisa; Johnson, Graham; Lin, Jiunn H; Kim, Doo Y; Mobley, William C; Rissman, Robert A; Tanzi, Rudolph E
发表日期：2017
文献求助 收藏

3D culture models of Alzheimer's disease: a road map to a "cure-in-a-dish"

阿尔茨海默病三维培养模型：通往“体外治愈”的路线图

期刊:Molecular Neurodegeneration
影响因子:17.5
doi:10.1186/s13024-016-0139-7
Choi, Se Hoon; Kim, Young Hye; Quinti, Luisa; Tanzi, Rudolph E; Kim, Doo Yeon
阿尔茨海默症
发表日期：2016
文献求助 收藏

Development and characterization of 3-(benzylsulfonamido)benzamides as potent and selective SIRT2 inhibitors.

开发和表征 3-(苄基磺酰胺基)苯甲酰胺类化合物作为强效选择性 SIRT2 抑制剂

期刊:European Journal of Medicinal Chemistry
影响因子:5.9
doi:10.1016/j.ejmech.2014.02.003
Khanfar Mohammad A, Quinti Luisa, Wang Hua, Choi Soo Hyuk, Kazantsev Aleksey G, Silverman Richard B
其它
发表日期：2014
文献求助 收藏

3-(N-arylsulfamoyl)benzamides, inhibitors of human sirtuin type 2 (SIRT2)

3-(N-芳基磺酰基)苯甲酰胺，人SIRT2抑制剂

期刊:Bioorganic & Medicinal Chemistry Letters
影响因子:2.2
doi:10.1016/j.bmcl.2012.02.089
Choi, Soo Hyuk; Quinti, Luisa; Kazantsev, Aleksey G; Silverman, Richard B
发表日期：2012
文献求助 收藏